Ampio Pharmaceuticals, Inc.
AMPE
$0.0217
$0.0196933.33%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -8.63M | -8.80M | -13.98M | -14.68M | -16.34M |
| Total Depreciation and Amortization | 127.00K | 310.00K | 657.00K | 988.00K | 1.05M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -74.00K | -322.00K | 566.00K | -2.53M | -2.87M |
| Change in Net Operating Assets | 15.00K | -1.74M | -3.18M | -2.26M | -2.97M |
| Cash from Operations | -8.56M | -10.55M | -15.94M | -18.49M | -21.13M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 98.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | 0.00 | -79.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -98.00K | 0.00 | 0.00 | 0.00 | -32.00K |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 0.00 | -111.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.56M | -10.55M | -15.94M | -18.49M | -21.24M |